Bexarotene
- Part D specialty tier in 78% of formularies (2026Q3)
- Targretin
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Bexarotene: storage and handling
- Freezing
- Not addressed
- Room temperature
- No allowance stated
- Back into the refrigerator
- Not addressed
- Light
- Protect from light
Label statement
Protect from light.
- Shaking
- Not addressed
All storage statements on the label (5)
- Protect from light.
- How should I store TARGRETIN? .
- Store TARGRETIN between 36° to 77°F (2° to 25°C). .
- Store the TARGRETIN bottle away from light, heat, and humidity. .
- The capsules should not be taken after the expiration date printed on the bottle.
FDA label version 16, effective April 30, 2020. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Medicare Part D coverage
5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.